Toward quality assessment of 3D printed oral dosage forms

Daniel Markl; Axel Zeitler; Thomas Rades; Jukka Rantanen; Johan Bøtker

doi:10.2217/3dp-2017-0016

Toward quality assessment of 3D printed oral dosage forms

Daniel Markl, Axel Zeitler, Thomas Rades, Jukka Rantanen, Johan Bøtker

Abstract

The additive manufacturing industry achieved a corporate annual growth rate of 25.9% according to the Forbes analysis of the Wohlers Report 2016. This high growth rate is placed in perspective when looking at the past 27 years where the corporate annual growth rate has averaged 26.2% each year indicating that additive manufacturing is clearly a growing industry. Such growth needs to be supported by suitable quality testing methods: with the economic success achieved in this market and the associated transition from mass production toward mass customization comes the need for new and innovative methods to assess the quality of the 3D printed geometries. This will be especially important for pharmaceutical products where a sub-standard quality of the final product can have detrimental consequences for patient health and safety.

Originalsprog	Dansk
Tidsskrift	Journal of 3D Printing in Medicine
Vol/bind	2
Udgave nummer	1
Sider (fra-til)	27-33
Antal sider	7
ISSN	2059-4755
DOI	https://doi.org/10.2217/3dp-2017-0016
Status	Udgivet - 15 dec. 2017

Adgang til dokumentet

10.2217/3dp-2017-0016

Citationsformater

@article{42e6440496b649e699af484744b32695,

title = "Toward quality assessment of 3D printed oral dosage forms",

abstract = "The additive manufacturing industry achieved a corporate annual growth rate of 25.9% according to the Forbes analysis of the Wohlers Report 2016. This high growth rate is placed in perspective when looking at the past 27 years where the corporate annual growth rate has averaged 26.2% each year indicating that additive manufacturing is clearly a growing industry. Such growth needs to be supported by suitable quality testing methods: with the economic success achieved in this market and the associated transition from mass production toward mass customization comes the need for new and innovative methods to assess the quality of the 3D printed geometries. This will be especially important for pharmaceutical products where a sub-standard quality of the final product can have detrimental consequences for patient health and safety.",

author = "Daniel Markl and Axel Zeitler and Thomas Rades and Jukka Rantanen and Johan B{\o}tker",

note = "doi: 10.2217/3dp-2017-0016",

year = "2017",

month = dec,

day = "15",

doi = "10.2217/3dp-2017-0016",

language = "Dansk",

volume = "2",

pages = "27--33",

journal = "Journal of 3 D Printing in Medicine",

issn = "2059-4755",

publisher = "Future Science",

number = "1",

}

TY - JOUR

T1 - Toward quality assessment of 3D printed oral dosage forms

AU - Markl, Daniel

AU - Zeitler, Axel

AU - Rades, Thomas

AU - Rantanen, Jukka

AU - Bøtker, Johan

N1 - doi: 10.2217/3dp-2017-0016

PY - 2017/12/15

Y1 - 2017/12/15

N2 - The additive manufacturing industry achieved a corporate annual growth rate of 25.9% according to the Forbes analysis of the Wohlers Report 2016. This high growth rate is placed in perspective when looking at the past 27 years where the corporate annual growth rate has averaged 26.2% each year indicating that additive manufacturing is clearly a growing industry. Such growth needs to be supported by suitable quality testing methods: with the economic success achieved in this market and the associated transition from mass production toward mass customization comes the need for new and innovative methods to assess the quality of the 3D printed geometries. This will be especially important for pharmaceutical products where a sub-standard quality of the final product can have detrimental consequences for patient health and safety.

AB - The additive manufacturing industry achieved a corporate annual growth rate of 25.9% according to the Forbes analysis of the Wohlers Report 2016. This high growth rate is placed in perspective when looking at the past 27 years where the corporate annual growth rate has averaged 26.2% each year indicating that additive manufacturing is clearly a growing industry. Such growth needs to be supported by suitable quality testing methods: with the economic success achieved in this market and the associated transition from mass production toward mass customization comes the need for new and innovative methods to assess the quality of the 3D printed geometries. This will be especially important for pharmaceutical products where a sub-standard quality of the final product can have detrimental consequences for patient health and safety.

U2 - 10.2217/3dp-2017-0016

DO - 10.2217/3dp-2017-0016

M3 - Tidsskriftartikel

SN - 2059-4755

VL - 2

SP - 27

EP - 33

JO - Journal of 3 D Printing in Medicine

JF - Journal of 3 D Printing in Medicine

IS - 1

ER -